LONDON (Reuters) – AstraZeneca has agreed to buy Bristol-Myers Squibb’s stake in the companies’ diabetes joint venture for up to $4.1 billion in a deal that will help return the group to growth, sending its shares to a new high.
Reuters: Business News article archive.
Comments are closed.
Visiting France? Get the best Paris deals at LinkParis.com before your trip.
Arrange a visit to see the D-Day landing beaches in Normandy, the castles of the Loire Valley, a Mont St. Michel tour, Paris Day Trips and more!
Get your NewsFlares.com now!
Email corrections to:
Send news tips to:
Write for us: